Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

868 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches.
Mashiach E, Alzate JD, De Nigris Vasconcellos F, Adams S, Santhumayor B, Meng Y, Schnurman Z, Donahue BR, Bernstein K, Orillac C, Bollam R, Kwa MJ, Meyers M, Oratz R, Novik Y, Silverman JS, Harter DH, Golfinos JG, Kondziolka D. Mashiach E, et al. Among authors: meyers m. J Neurooncol. 2024 May;168(1):99-109. doi: 10.1007/s11060-024-04651-0. Epub 2024 Apr 17. J Neurooncol. 2024. PMID: 38630386
Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic Therapies.
Mashiach E, Alzate JD, De Nigris Vasconcellos F, Bernstein K, Donahue BR, Schnurman Z, Gurewitz J, Rotman LE, Adams S, Meyers M, Oratz R, Novik Y, Kwa MJ, Silverman JS, Sulman EP, Golfinos JG, Kondziolka D. Mashiach E, et al. Among authors: meyers m. Neurosurgery. 2024 Jan 1;94(1):154-164. doi: 10.1227/neu.0000000000002640. Epub 2023 Aug 15. Neurosurgery. 2024. PMID: 37581437 Review.
Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic.
Marks DK, Budhathoki N, Kucharczyk J, Fa'ak F, D'Abreo N, Kwa M, Plasilova M, Dhage S, Soe PP, Becker D, Hindenburg A, Lee J, Winner M, Okpara C, Daly A, Shah D, Ramdhanny A, Meyers M, Oratz R, Speyer J, Novik Y, Schnabel F, Jones SA, Adams S. Marks DK, et al. Among authors: meyers m. Oncologist. 2022 Mar 4;27(2):89-96. doi: 10.1093/oncolo/oyab042. Oncologist. 2022. PMID: 35641208 Free PMC article.
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer.
Kwa M, Li X, Novik Y, Oratz R, Jhaveri K, Wu J, Gu P, Meyers M, Muggia F, Speyer J, Iwano A, Bonakdar M, Kozhaya L, Tavukcuoglu E, Budan B, Raad R, Goldberg JD, Unutmaz D, Adams S. Kwa M, et al. Among authors: meyers m. Breast Cancer Res Treat. 2018 Feb;168(1):57-67. doi: 10.1007/s10549-017-4570-4. Epub 2017 Nov 9. Breast Cancer Res Treat. 2018. PMID: 29124456 Clinical Trial.
Barriers and engagement in breast cancer survivorship wellness activities.
Szuhany KL, Malgaroli M, Riley G, Miron CD, Suzuki R, Park JH, Rosenthal J, Chachoua A, Meyers M, Simon NM. Szuhany KL, et al. Among authors: meyers m. Breast Cancer Res Treat. 2021 Jul;188(1):317-325. doi: 10.1007/s10549-021-06279-4. Epub 2021 Jun 7. Breast Cancer Res Treat. 2021. PMID: 34095986 Free PMC article.
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.
Speyer JL, Green MD, Zeleniuch-Jacquotte A, Wernz JC, Rey M, Sanger J, Kramer E, Ferrans V, Hochster H, Meyers M, et al. Speyer JL, et al. Among authors: meyers m. J Clin Oncol. 1992 Jan;10(1):117-27. doi: 10.1200/JCO.1992.10.1.117. J Clin Oncol. 1992. PMID: 1727913 Clinical Trial.
868 results